# OnCo record nct05218408 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05218408/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05218408", "NCT05218408" ;
  schema:name "CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type"@en ;
  schema:description "A phase 1/2 trial of CYNK-001 run by Celularity Incorporated, withdrawn before enrolling."@en ;
  schema:url <https://onco.cc/trials/nct05218408/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05218408> ;
  onco:status "withdrawn" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  onco:cancers <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/cynk-001/> ;
  onco:companies <https://onco.cc/companies/celularity/> .